Free Trial

Amarin (AMRN) Stock Forecast & Price Target

Amarin logo
$0.46 -0.01 (-1.18%)
(As of 12/20/2024 05:31 PM ET)

Amarin - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for Amarin in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for AMRN.

Consensus Price Target

N/A

Get the Latest News and Ratings for AMRN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Amarin and its competitors.

Sign Up

AMRN Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price TargetN/AN/A$1.00$1.08
Forecasted UpsideN/AN/A69.46% Upside18.89% Upside
Consensus Rating
Buy
Buy
Hold
Reduce

AMRN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AMRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Amarin Stock vs. The Competition

TypeAmarinMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.81
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted UpsideN/A25,828.60% Upside14.54% Upside
News Sentiment Rating
Neutral News

See Recent AMRN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Cantor Fitzgerald
4 of 5 stars
L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
11/20/2023JPMorgan Chase & Co.
3 of 5 stars
 Reiterated RatingUnderweight
10/25/2023Jefferies Financial Group
2 of 5 stars
 DowngradeBuy ➝ Hold$3.00 ➝ $1.00+31.53%
7/20/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell$1.50 ➝ $1.00-7.41%
7/19/2023Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$2.00 ➝ $1.25-12.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:53 AM ET.


AMRN Forecast - Frequently Asked Questions

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amarin in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AMRN shares.

According to analysts, Amarin's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Amarin more than other "medical" companies. The consensus rating for Amarin is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AMRN compares to other companies.


This page (NASDAQ:AMRN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners